Top Broker Regulation Stories
IBM fights Congress over Watson
By Anna EdneyWatson, an artificial intelligence technology that IBM wants to sell to help doctors diagnose diseases, will largely escape the oversight of regulators if the computer giant wins a two-year Washington lobbying push.
